| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.0094 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |